MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED™ X™) Post-Approval Study

  • Clinical Trial Information

    Trial Contact: Carlo, Charlene S; Monserrate, Francheska

    Trial Phone: 321.841.1324 ; 321-841-4717

  • IRB No: W22.124.06

    Protocol Abbrev: FRED-X

    Principal Investigator: Jay Ashok Vachhani, MD

    Phase: Device: Category N/A

    Age Group: Adult

    Secondary Protocol No: CL11023

    Treatment: The FRED™ X™ System

    Therapies Involved: Surgery ID: NCT05409989

  • Objective

    The objective of this study is to generate contemporaneous clinical data to facilitate a reasonable comparison of the performance of the FRED™ X™ device with the performance of the FRED™ device.

  • Key Eligibility

    Subject has single target aneurysm in the internal carotid artery from petrous segment to the terminus of the internal carotid artery.